Viewing Study NCT05468294


Ignite Creation Date: 2025-12-25 @ 1:46 AM
Ignite Modification Date: 2025-12-31 @ 11:04 PM
Study NCT ID: NCT05468294
Status: UNKNOWN
Last Update Posted: 2022-07-21
First Post: 2022-06-23
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: F16IL2 in Combination With Nivolumab in Patients With Non-small Cell Lung Cancer
Sponsor: Philogen S.p.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module